GLP-1 drugs are best known today for helping people lose weight and manage type 2 diabetes. But new research shows these medications may do much more. Scientists are now studying GLP-1 drugs for a wide range of health problems, from heart disease to liver disease and even brain disorders.

How GLP-1 Drugs Work in the Body

GLP-1 drugs copy the action of a natural hormone called glucagon-like peptide-1. This hormone is released in the gut after eating and sends signals to the brain and other organs.

GLP-1 drugs work in several important ways:

  • They reduce appetite by acting on brain centers that control hunger.
  • They slow stomach emptying, helping people feel full longer.
  • They increase insulin release and lower blood sugar.
  • They reduce inflammation and improve blood vessel function.

These combined effects explain why GLP-1 drugs help with weight loss and blood sugar control. Researchers now believe these same actions may help treat other diseases.

New Uses for GLP-1 Drugs Being Studied

Scientists are actively testing GLP-1 drugs for conditions beyond diabetes and obesity. Some of the most promising areas include:

Heart and kidney disease
 Large studies show GLP-1 drugs lower the risk of heart attack, stroke, heart failure, and kidney disease in people with diabetes and obesity. These benefits sometimes appear even before major weight loss happens.

Metabolic liver disease (fatty liver disease)
 GLP-1 drugs are being studied for metabolic liver disease, including inflammation and scarring of the liver. Several trials show improvements in liver inflammation, and large studies are ongoing to see if they can slow or reverse liver damage.

Brain and nerve conditions
 Early studies suggest GLP-1 drugs may protect brain cells. Researchers are testing them in Parkinson disease and Alzheimer disease. Some trials show slower worsening of symptoms, but results are still mixed and more research is needed.

Addiction and compulsive behaviors
 Doctors have noticed that some people taking GLP-1 drugs report less interest in alcohol, smoking, or other addictive behaviors. Small studies suggest GLP-1 drugs may reduce cravings, but this is still experimental.

Which GLP-1 Drugs Are Being Studied for New Uses

Researchers are studying both existing GLP-1 drugs already on the market and newer medicines still in development to see if they can help treat conditions beyond diabetes and weight loss.

Existing GLP-1 Drugs Being Studied for New Uses

These medications are already approved for diabetes and/or obesity but are being tested for other health benefits:

  • Semaglutide
     Being studied for heart disease, kidney disease, fatty liver disease, brain conditions like Alzheimer and Parkinson disease, and possible effects on alcohol and other cravings.
  • Liraglutide
     Under study for heart and kidney protection, liver disease, and effects on brain pathways involved in appetite and addiction.
  • Dulaglutide
     Being researched for long-term heart and kidney benefits and its role in reducing inflammation linked to metabolic disease.
  • Tirzepatide
     Targets GLP-1 and GIP hormones and is being studied for stronger weight loss, heart risk reduction, and fatty liver disease.

Newer and Investigational GLP-1–Based Drugs

These medicines are still in clinical trials and are designed to improve results or make treatment easier:

  • Retatrutide
     Targets three hormone pathways and is being studied for obesity-related diseases, heart health, and metabolic improvement.
  • Cagrilintide
     Often studied with semaglutide to improve appetite control and enhance weight loss.
  • Maritide (AMG-133)
     A long-acting monthly injection being studied for obesity and metabolic disease to improve convenience and adherence.
  • Orforglipron
     An oral GLP-1 drug taken as a pill, being studied for weight loss and diabetes management.

Together, these studies show that GLP-1 medicines may soon play a larger role in treating heart, liver, brain, and metabolic diseases—not just diabetes and obesity.

Why Researchers Are Excited About These Findings

GLP-1 drugs affect many organs at the same time, including the brain, heart, kidneys, liver, and fat tissue. Because of this, scientists believe they could become part of treatment plans for many chronic diseases linked to obesity and metabolism.

At the same time, researchers stress the need for long-term safety studies, especially as higher doses and new drug combinations are tested.

What This Research Means for Patients

Right now, GLP-1 drugs are approved mainly for type 2 diabetes and weight management. Their use for other conditions is still research-based, not standard care.

If future studies confirm these benefits, GLP-1 drugs may:

  • Be used earlier to prevent heart and kidney disease
  • Become treatments for fatty liver disease
  • Play a role in managing some brain and addiction-related conditions

For now, these uses are not approved by the FDA.  Anyone considering these medications should talk with a healthcare professional and use them only as prescribed by their provider.

Source:

Drucker DJ. Efficacy and safety of GLP-1 medicines for type 2 diabetes and obesity. Diabetes Care. 2024;47(11):1873-1888. doi:10.2337/dci24-0003. Accessed by: https://diabetesjournals.org/care/article/47/11/1873/156807/Efficacy-and-Safety-of-GLP-1-Medicines-for-Type-2

You May Also Like